These studies were approved by the Institutional Review Board of Benaroya Research Institute (BRI, Seattle, WA) and Seattle Children’s Hospital. All DQ8+DQ2 and DQ8+DQ2+ participants were volunteers of Caucasian descent and were recruited with written consent from participating individuals or assent and the consent of their guardians if participants were minors (tables S2 and S3). HLA typing was conducted by the BRI sequencing and genotyping core facilities. Autoantibodies were measured at the Barbara Davis Center for Childhood Diabetes.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.